Frontiers in Immunology · 2021 · 22 citations · 29 references
Veterinary MedicineCardiologyInfectious DiseasesClinical CardiologyInflammationMolecular VirologyCardiac BiomarkersCardiovascular DiseaseCytokine-mediated PathologyFibrosisDisease Severity EstimationEchocardiographic QuantificationInflammatory Cardiac BiomarkersLeft Ventricular InvolvementOrgan FibrosisSars-cov-2 InfectionSevere Acute Respiratory Syndrome
Increased left ventricular fibrosis has been reported in patients hospitalized with coronavirus disease 2019 (COVID-19). It is unclear whether this fibrosis is a consequence of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection or a risk factor for severe disease progression. We observed increased fibrosis in the left ventricular myocardium of deceased COVID-19 patients, compared with matched controls. We also detected increased mRNA levels of soluble interleukin-1 receptor-like 1 (sIL1-RL1) and transforming growth factor β1 (TGF-β1) in the left ventricular myocardium of deceased COVID-19 patients. Biochemical analysis of blood sampled from patients admitted to the emergency department (ED) with COVID-19 revealed highly elevated levels of TGF-β1 mRNA in these patients compared to controls. Left ventricular strain measured by echocardiography as a marker of pre-existing cardiac fibrosis correlated strongly with blood TGF-β1 mRNA levels and predicted disease severity in COVID-19 patients. In the left ventricular myocardium and lungs of COVID-19 patients, we found increased neuropilin-1 (NRP-1) RNA levels, which correlated strongly with the prevalence of pulmonary SARS-CoV-2 nucleocapsid. Cardiac and pulmonary fibrosis may therefore predispose these patients to increased cellular viral entry in the lung, which may explain the worse clinical outcome observed in our cohort. Our study demonstrates that patients at risk of clinical deterioration can be identified early by echocardiographic strain analysis and quantification of blood TGF-β1 mRNA performed at the time of first medical contact.
29
Valentina O. Püntmann, Maria Ludovica Carerj, Imke Wieters et al. · JAMA Cardiology · 2020 · 2.3K citations · Full text
Veterinary Medicine, Infectious Diseases, Internal Medicine +10
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti‐Castelvetri, Ravi Ojha, Liliana D. Pedro et al. · Science · 2020 · 2K citations · Full text
A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation
Jeffrey R. Erickson, Mei-ling A. Joiner, Xiaoqun Guan et al. · Cell · 2008 · 1.1K citations · Full text
Myocardial Localization of Coronavirus in COVID-19 Cardiogenic Shock
Guido Tavazzi, Carlo Pellegrini, M. Maurelli et al. · European Journal of Heart Failure · 2020 · 945 citations · Full text